Raymond James & Associates’s Duck Creek Technologies, Inc. Common Stock DCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-338,794
Closed -$4.08M 4133
2022
Q4
$4.08M Buy
338,794
+50,603
+18% +$580K ﹤0.01% 1539
2022
Q3
$3.42M Buy
288,191
+7,644
+3% +$101K ﹤0.01% 1628
2022
Q2
$4.17M Buy
280,547
+6,061
+2% +$106K ﹤0.01% 1521
2022
Q1
$6.07M Sell
274,486
-241,625
-47% -$5.78M 0.01% 1370
2021
Q4
$15.5M Buy
516,111
+62,592
+14% +$2.01M 0.01% 876
2021
Q3
$20.1M Buy
453,519
+39,287
+9% +$1.78M 0.02% 705
2021
Q2
$18M Buy
414,232
+88,315
+27% +$3.59M 0.02% 767
2021
Q1
$14.7M Buy
325,917
+305,563
+1,501% +$14.7M 0.01% 821
2020
Q4
$881K Buy
+20,354
New +$862K ﹤0.01% 2427

Other funds holding DCT

Raymond James & Associates's DCT Position: Q1 2023 in Review

Raymond James & Associates sold out of Duck Creek Technologies, Inc. Common Stock (DCT) in Q1 2023, closing a stake of 338,794 shares — an estimated $4.08M sold.

Raymond James & Associates first reported a position in DCT in Q4 2020 and held it in 9 quarters. The position peaked at $20.1M in Q3 2021. 4 funds tracked by Wall St. Rank hold DCT as of Q1 2023.

  • Raymond James & Associates reported no remaining Duck Creek Technologies, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 338,794 Duck Creek Technologies, Inc. Common Stock shares in Q1 2023, an estimated $4.08M.
  • Raymond James & Associates first reported a position in Duck Creek Technologies, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Raymond James & Associates's Duck Creek Technologies, Inc. Common Stock position peaked at $20.1M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Duck Creek Technologies, Inc. Common Stock as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.